LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| MCF7 | Sirolimus | 0.5059 |
| MCF7 | Ruxolitinib | 0.0218 |
| MCF7 | Saracatinib | 0.5672 |
| MCF7 | SB590885 | 0.0427 |
| MCF7 | Selumetinib | 0.3865 |
| MCF7 | Sigma A6730 | 0.4425 |
| MCF7 | Sorafenib | 0.1636 |
| MCF7 | SU11274 | 0.1529 |
| MCF7 | Fedratinib | 0.4195 |
| MCF7 | TGX221 | 0.1198 |
| MCF7 | Torin1 | 0.9471 |
| MCF7 | Torin2 | 1.0362 |
| MCF7 | Tozasertib | 0.9322 |
| MCF7 | Trametinib | 0.6137 |
| MCF7 | TWS119 | 0.1925 |
| MCF7 | Vemurafenib | 0.0026 |
| MCF7 | WH-4-025 | 0.6207 |
| MCF7 | Withaferin A | 0.6858 |
| MCF7 | WYE-125132 | 0.8763 |
| MCF7 | WZ-4-145 | 0.5894 |
| MCF7 | WZ3105 | 1.2821 |
| MCF7 | XL147 | -0.0161 |
| MCF7 | XMD11-50 | 0.5146 |
| MCF7 | XMD11-85h | 0.2404 |
| MCF7 | XMD16-144 | 0.8821 |